| Serial Number | 98432118 |
| Word Mark | MIRADOR360 |
| Filing Date | Monday, March 4, 2024 |
| Status | 638 - NEW APPLICATION - ASSIGNED TO EXAMINER |
| Status Date | Wednesday, September 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Pseudo Mark | MIRADOR THREE SIXTY |
| Pseudo Mark | MIRADOR THREE SIX ZERO |
| Pseudo Mark | MIRADOR THREE HUNDRED SIXTY |
| Goods and Services | Providing the service of collecting and analyzing patient data and genetic information for pharmaceutical drug development and diagnostics development (including companion diagnostics development and complementary diagnostics development); providing the service of collecting and analyzing patient data including genetic information for selecting and validating therapeutic targets for pharmaceutical development as well as for predicting, measuring or evaluating the performance of therapeutic molecules directed at therapeutic targets; providing the service of collecting and analyzing patient data including genetic information for selecting and validating biomarkers and other criteria for diagnostics (including companion diagnostics development and complementary diagnostics development) as well as for predicting, measuring or evaluating the performance of the diagnostics; providing the service of collecting and analyzing patient data including genetic information for selecting and validating biomarkers and other criteria for selecting patients for inclusion in clinical treatment (including clinical trials) as well as for predicting, measuring or evaluating the performance of the patient selecting criteria; providing the service of collecting patient data and genetic information and analysis of such data for identifying and recruiting patients for participation in clinical trials for pharmaceutical drug development, matching patients with clinical trials and for measuring and monitoring the performance of clinical trials for pharmaceutical drug development; providing a platform as a service featuring a computer software platform for selecting, validating and evaluating therapeutic targets and therapeutic molecules in the field of pharmaceutical development; providing a platform as a service featuring a computer software platform or computer service for selecting, validating and evaluating biomarkers and other patient-selecting or patient-identifying criteria in the field of diagnostic development (including companion diagnostics development and complementary diagnostics development) |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 4, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Mirador Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Monday, March 4, 2024 | NEW APPLICATION ENTERED |
| Monday, July 15, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, September 18, 2024 | ASSIGNED TO EXAMINER |